|
KMID : 1161520120160040274
|
|
Animal Cells and Systems
2012 Volume.16 No. 4 p.274 ~ p.279
|
|
|
Thymoquinone (TQ) regulates cyclooxygenase-2 expression and prostaglandin E2 production through PI3kinase (PI3K)/p38 kinase pathway in human breast cancer cell line, MDA-MB-231
|
|
Yu Seon-Mi
Kim Song-Ja
|
|
|
Abstract
|
|
|
|
Thymoquinone (TQ), a drug extracted from the black seeds of Nigella sativa, has been shown to exhibit anti-inflammatory, anti-oxidant, and anti-neoplastic effects in numerous cancer cells. The effects of TQ on cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in MDA-MB-231, however, remain poorly understood. Western blot analysis and immunofluorescence staining were performed to study the expression levels of inflammation regulatory proteins in MDA-MB-231. PGE2 assay was conducted to explore the TQ-induced production of PGE2. In this study, we investigated the effects of TQ on COX-2 expression and PGE2 production in MDA-MB-231. TQ significantly induced COX-2 expression and increased PGE2 production in a dose-dependent manner, as determined by a Western blot analysis and PGE2 assay. Furthermore, the activation of Akt and p38 kinase, respectively, was up-regulated in TQ treated cells. Inhibition of p38 kinase with SB203580 and PI3kinase (PI3K) with LY294002 abolished TQ-caused COX-2 expression and decreased PGE2 production. These results collectively demonstrate that TQ effectively modulates COX-2 expression and PGE2 production via PI3K and p38 kinase pathways in the human breast cancer cell line MDA-MB-231.
|
|
|
KEYWORD
|
|
|
cyclooxygenase-2 (COX-2), MDA-MB-231, prostaglandin E2 (PGE2), thymoquinone (TQ)
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|